RankingsPricing
  1. US-listed companies
  2. Akebia Therapeutics, Inc.
  3. Financials
  4. Pretax margin (%)

Akebia Therapeutics, Inc.AKBA

Market cap
$438.6M
P/E ratio
SummaryFinancials
Period EndPretax margin (%) YoY (%)
Dec 31, 2024-43.3+62.42%
Dec 31, 2023-26.7-15.66%
Dec 31, 2022-31.6-76.11%
Dec 31, 2021-132.4+1.99%
Dec 31, 2020-129.9+51.94%
Dec 31, 2019-85.5+3.26%
Dec 31, 2018-82.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)